Yang Tao, Li Xiao-Na, Li Li, Wu Qi-Mei, Gao Peng-Zhi, Wang Hong-Lei, Zhao Wei
Department of Hepatobiliary Surgery, The First Hospital of Shijiazhuang City, Shijiazhuang, China.
Tumour Biol. 2014 Nov;35(11):11199-207. doi: 10.1007/s13277-014-2398-7. Epub 2014 Aug 10.
Sox17, an antagonist of canonical Wnt/β-catenin signaling, inhibits several malignant carcinogenesis and progression. However, little is known about Sox17 in hepatocellular carcinoma (HCC). Here, we found that Sox17 is downregulated in HCC tissue. Furthermore, Sox17 inhibits cell proliferation and migration in HCC. KIF14, a member of kinesin superfamily protein (KIFs), is an oncogene in a variety of malignant tumors including HCC. We demonstrated that Sox17 is negatively related to KIF14 expression in HCC tissue and Sox17 inhibits HCC cell proliferation and migration by transcriptional downregulation of KIF14 expression. Our results may provide a strategy for blocking HCC carcinogenesis and progression.
Sox17作为经典Wnt/β-连环蛋白信号通路的拮抗剂,可抑制多种恶性肿瘤的发生和进展。然而,关于Sox17在肝细胞癌(HCC)中的作用却知之甚少。在此,我们发现Sox17在HCC组织中表达下调。此外,Sox17可抑制HCC细胞的增殖和迁移。驱动蛋白超家族蛋白(KIFs)成员之一的KIF14是包括HCC在内的多种恶性肿瘤中的一种癌基因。我们证明,Sox17与HCC组织中KIF14的表达呈负相关,且Sox17通过转录下调KIF14的表达来抑制HCC细胞的增殖和迁移。我们的研究结果可能为阻断HCC的发生和进展提供一种策略。